These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 33915010)

  • 1. Carbapenem-resistant Serratia marcescens bloodstream infection in hematopoietic stem cell transplantation patients: Will it be the next challenge?
    do Prado GVB; Mendes ET; Martins RCR; Perdigão-Neto LV; Freire MP; Spadão F; de Castro Lima VAC; Rossi F; Guimarães T; Levin AS; Rocha V; Costa SF
    Transpl Infect Dis; 2021 Aug; 23(4):e13630. PubMed ID: 33915010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preliminary exploration on the mechanism of the carbapenem-resistance transformation of Serratia marcescens in vivo.
    Xu Q; Zheng B; Li K; Shen P; Xiao Y
    BMC Genomics; 2024 Jan; 25(1):2. PubMed ID: 38166565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of Serratia marcescens isolates possessing carbapenem-hydrolysing β-lactamase KPC-2 from China.
    Lin X; Hu Q; Zhang R; Hu Y; Xu X; Lv H
    J Hosp Infect; 2016 Sep; 94(1):65-7. PubMed ID: 27160868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonization by multidrug-resistant bacteria in hematological patients undergoing hematopoietic stem cell transplantation and clinical outcomes: A single-center retrospective cohort study.
    Santos ES; Lima ACM; Breda GL; Tomaz APO; Nabhan SK; Funke VAM; Loth G; Nogueira KDS
    Transpl Infect Dis; 2023 Oct; 25(5):e14119. PubMed ID: 37561358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases.
    Queenan AM; Shang W; Schreckenberger P; Lolans K; Bush K; Quinn J
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3485-7. PubMed ID: 17005839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coproduction of KPC-2 and IMP-10 in Carbapenem-Resistant Serratia marcescens Isolates from an Outbreak in a Brazilian Teaching Hospital.
    Silva KE; Cayô R; Carvalhaes CG; Patussi Correia Sacchi F; Rodrigues-Costa F; Ramos da Silva AC; Croda J; Gales AC; Simionatto S
    J Clin Microbiol; 2015 Jul; 53(7):2324-8. PubMed ID: 25878341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Were all carbapenemases created equal? Treatment of NDM-producing extensively drug-resistant Enterobacteriaceae: a case report and literature review.
    Chibabhai V; Nana T; Bosman N; Thomas T; Lowman W
    Infection; 2018 Feb; 46(1):1-13. PubMed ID: 28916900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology of carbapenem resistant gram-negative bacilli from infected pediatric population in tertiary - care hospitals in Medellín, Colombia: an increasing problem.
    Vanegas JM; Parra OL; Jiménez JN
    BMC Infect Dis; 2016 Sep; 16(1):463. PubMed ID: 27585707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Carbapenem Resistance in Clinical Gram-Negative Pathogens Isolated in Egypt.
    Khalifa HO; Soliman AM; Ahmed AM; Shimamoto T; Hara T; Ikeda M; Kuroo Y; Kayama S; Sugai M; Shimamoto T
    Microb Drug Resist; 2017 Oct; 23(7):838-844. PubMed ID: 28191865
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Fu Y; Liu W; Liu M; Zhang J; Yang M; Wang T; Qian W
    Biofouling; 2021 Mar; 37(3):341-351. PubMed ID: 33947279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTX-M and TEM as predominant types of extended spectrum beta-lactamases among Serratia marcescens isolated from solid organ recipients.
    Mlynarczyk A; Szymanek K; Sawicka-Grzelak A; Pazik J; Buczkowska T; Durlik M; Lagiewska B; Pacholczyk M; Chmura A; Paczek L; Mlynarczyk G
    Transplant Proc; 2009 Oct; 41(8):3253-5. PubMed ID: 19857723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of carbapenem resistant plasmid isolated from Serratia marcescens].
    Yosue T
    Fukuoka Igaku Zasshi; 1996 May; 87(5):116-26. PubMed ID: 8690335
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Bielli A; Piazza A; Cento V; Comandatore F; Lepera V; Gatti M; Brioschi P; Vismara C; Bandi C; Perno CF
    J Med Microbiol; 2020 Jan; 69(1):82-86. PubMed ID: 31904319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical, epidemiological and microbiological characterization of bacteremia produced by carbapenem-resistant enterobacteria in a university hospital in Córdoba, Argentina].
    Lipari FG; Hernández D; Vilaró M; Caeiro JP; Saka HA
    Rev Chilena Infectol; 2020 Aug; 37(4):362-370. PubMed ID: 33399656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid-mediated carbapenem-hydrolysing beta-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China.
    Zhang R; Zhou HW; Cai JC; Chen GX
    J Antimicrob Chemother; 2007 Mar; 59(3):574-6. PubMed ID: 17251347
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment Outcomes in Infections Caused by "SPICE" (Serratia, Pseudomonas, Indole-positive Proteus, Citrobacter, and Enterobacter) Organisms: Carbapenem versus Noncarbapenem Regimens.
    Moy S; Sharma R
    Clin Ther; 2017 Jan; 39(1):170-176. PubMed ID: 28034519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
    Tamma PD; Goodman KE; Harris AD; Tekle T; Roberts A; Taiwo A; Simner PJ
    Clin Infect Dis; 2017 Feb; 64(3):257-264. PubMed ID: 28013264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report.
    Oliva A; Cipolla A; Gizzi F; D'Abramo A; Favaro M; De Angelis M; Ferretti G; Russo G; Iannetta M; Mastroianni CM; Mascellino MT; Vullo V
    Medicine (Baltimore); 2016 Feb; 95(7):e2243. PubMed ID: 26886594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serratia marcescens harboring SME-4 in Brazil: A silent threat.
    Cayô R; Leme RC; Streling AP; Matos AP; Nodari CS; Chaves JR; Brandão JL; de Almeida MF; Carrareto V; de Castro Pereira MA; de Almeida JP; Ferreira DC; Gales AC
    Diagn Microbiol Infect Dis; 2017 Apr; 87(4):357-358. PubMed ID: 28159445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea.
    Kim SY; Shin J; Shin SY; Ko KS
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):486-90. PubMed ID: 23688521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.